ERBB2 and breast carcinoma: Given that high collagen deposition and alignment contribute to breast cancer invasion through overexpression of EGFR, ERBB2, CD44 and other receptors in the microenvironment, which further induce tumor invasion and metastasis through the transduction of downstream PI3K/Akt, MAPK and other signaling pathways (23–26).